Anticonvulsant hypersensitivity syndrome

International Journal of Dermatology

Volumn 44, Issue 7, 2005, Pages 594-598

  Kaminsky, Ana ^a   Moreno, M ^a   Diaz M ^a   Charas, V ^a   Bravo, G ^a   Kien, C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBAMAZEPINE; CLONAZEPAM; GAMMA GLUTAMYLTRANSFERASE; GLUCOCORTICOID; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PHENOBARBITAL; PHENYTOIN;

ACANTHOSIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CELL INFILTRATION; CONVULSION; DISEASE SEVERITY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ECZEMA; EDEMA; EOSINOPHIL; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; ERYTHRODERMA; FEMALE; HEMATOCRIT; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LEUKOCYTOSIS; LIMB; LYMPHOCYTOSIS; MALE; NEUTROPHIL; PARAKERATOSIS; PROTHROMBIN TIME; PRURITUS; SKIN BIOPSY; SKIN EXFOLIATION; TRUNK;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DRUG ERUPTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PHENYTOIN; TREATMENT OUTCOME;

EID: 21844441137     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02233.x     Document Type: Article

References (19)

1. Chaiken BH, et al. Dilantin hypersensitivity: Report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950; 242: 897-898.
2. Tennis P, Stern R. Risk of serious cutaneous disorders after initiation of use of pheniyoin, carbamazepine or sodium valproate: a record linkage study. Neurology 1997; 49: 542-546.
3. Vittorio C, Muglia J. Anticonvulsivant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-2290.
4. Redondo P, de Felipe I, de la Iña A, et al. Drug-induced hypersensitivity syndrome and toxic epidermal necrolisis. Treatment with N-acetylcysteine. Br J Dermatol 1997; 136: 645-646.
5. Bocquel H, Bagot M, Roujeau JC. Drug induced pseudolinfoma and drug hypersensitivity (drug rash with eosinofilia and systemic symptoms). Semin Cutan Med Surg 1996; 15: 250.
6. Shapiro L, Shear N. Mechanisms of drug reactions: the metabolic track. Semin Cutan Surg 1996; 115: 217-227.
7. Gupta A, Eggo M, Uetrecht J et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsivants and sulfonamides. Clin Pharmacol Ther 1992; 51: 56-67.
8. Gleichmann H. Studies of the mechanism of drug sensitization: T-cell dependent popliteal lymph node reaction to dhifenylhydantoin. Clin Inmunol Inmunopathol 1981; 118: 203-211.
9. Spielberg S, Gordon G, Blake D et al. Anticonvulsivant toxicity in vitro: possible role of arene oxides. J Pharmacol Exp Ther 1981; 217: 386-389.
10. Yoo JH, et al. Hypersensitivity syndrome with an epoxide hydrolase defect. Br J Dermatol 1999; 140: 181-183.
11. Aihara M, et al. Anticonvulsivant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br. J. Dermatol 20001; 144: 1231-4.
12. Chopra S, Levell NJ, Cowley G, et al. Systemic corticoesteroids in the phenytoin. hypersensitivity syndrome. Br J Dermatol 1996; 134: 1109-1112.
13. Reents S, Luginbuhl W. Davis. Phenytoin, carbamazepine cross-sensitivity. Ann Pharmacother 1989; 23: 235-236.
14. Knowels S, Shapiro L, Shear N. Anticonvulsivant hypersensitivity syndrome. Incidence, prevention and management. Drug Safety 1999; 21: 498-501.
15. Handfield-Jones S, Jenkins R, Whittaker S, et al. The anticonvulsivant hypersensitivity syndrome. Br J Dermatol 1991; 129: 175-177.
16. De Vriese et al. Carbamazepine hypersensitivity syndrome: report of four cases and review of the literature. Medicine (Baltimore), 1995; 74: 144-151.
17. Iemoli E, Vivirito M, Coen M, et al. Anticonvulsivant hypersensitivity syndrome due to carbamazepine. Inmunology 1999; 54: 1329-1330.
18. Brown T, Apple J, Kasteler J, et al. Hypersensitive reaction in a child due to lamotrigine. Pediatric Dermatol 1999; 16: 46-49.
19. Silverman A, Fairley J, Wong C. Cutaneous and inmunologic reactions to phenytoin. J Am Acad Dermatol 1988; 4: 721-741.